Acne
Actinic Keratosis
Aesthetics
Alopecia
Atopic Dermatitis
Buy-and-Bill
COVID-19
Case-Based Roundtable
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Drug Watch
Eczema
General Dermatology
Hidradenitis Suppurativa
Melasma
NP and PA
Pediatric Dermatology
Pigmentary Disorders
Practice Management
Precision Medicine and Biologics
Prurigo Nodularis
Psoriasis
Psoriatic Arthritis
Rare Disease
Rosacea
Skin Cancer
Vitiligo
Wound Care

Updates in Pediatric Atopic Dermatitis : Episode 12

Opinion

Video

March 10, 2025

Future Directions for Pediatric Atopic Dermatitis Management and Research

Author(s):

Lisa Swanson, MD, FAAD,Lawrence Eichenfield, MD

Panelists discuss the areas of research that need more attention in pediatric atopic dermatitis (AD) management, highlighting gaps in understanding the long-term effects of treatments, the genetic underpinnings of the disease, and strategies for improving early diagnosis and personalized care.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP: 1.Updates in Pediatric Atopic Dermatitis

EP: 2.Pathophysiology and Role of Type 2 Inflammation in Pediatric Atopic Dermatitis

EP: 3.Talking to Patients and Families About Type 2 Inflammatory Conditions

EP: 4.Unpacking the Atopic Dermatitis Burden of Disease With Patients and Families

EP: 5.Unique Challenges in Managing Atopic Dermatitis in Pediatric Patients

EP: 6.New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Ruxolitinib

EP: 7.New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Roflumilast

EP: 8.New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Tapinarof

EP: 9.New Systemic Therapies for Pediatric Atopic Dermatitis: Dupilumab and IL-13 Inhibitors

EP: 10.Understanding and Treating Pediatric AD Inside and Out

EP: 11.New Systemic Therapies for Pediatric Atopic Dermatitis: Nemolizumab and Oral JAK Inhibitors

Now Viewing

EP: 12.Future Directions for Pediatric Atopic Dermatitis Management and Research

Video content above is prompted by the following:

What areas of research do you think need more attention in pediatric AD management?

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!

Related Videos

Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care

Current Unmet Needs and Emerging Solutions in Atopic Dermatitis Management

Implementation Factors Affecting Ruxolitinib Adoption in Pediatric Dermatology Practice

Regulatory Challenges and Clinical Differentiators for Pediatric Atopic Dermatitis Treatments

Evaluating the Impact of Topical JAK Inhibitors on Pediatric Atopic Dermatitis Guidelines

The Future of Pediatric Atopic Dermatitis Treatment and Emerging Therapies

What Lies Ahead for GPP Diagnosis and Management

Case 3: High-Risk Patient with GPP Treatment Approach

Future Directions for IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis Care

Future Perspectives: Can Innovative Topical Therapies Like Ruxolitinib Reduce Systemic Treatment Dependency in Pediatric AD?